𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia

✍ Scribed by Thiery, J. ;Creutzfeldt, C. ;Creutzfeldt, W. ;Walli, A. K. ;Seidel, D.

Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
839 KB
Volume
68
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term effects of LDL apheresis in pa
Long-term effects of LDL apheresis in patients with severe hypercholesterolemia
✍ Bruce S. Sachais; Julie Katz; Joyce Ross; Daniel J. Rader πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism involving mutations in the LDL receptor (LDL-R). Patients with mutation in one (heterozygous) or both (homozygous) genes have markedly elevated LDL cholesterol and are at increased risk for coronary heart disease (

Short-term effects of treatment with sim
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia
✍ K. Purvis; A. Tollefsrud; H. Rui; E. Haug; J. Norseth; L. Viksmoen; L. Ose; H. L πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 415 KB

The effects of simvastatin 40 mg per day for 14 weeks on the pituitary-testis axis of 19 men with familial hypercholesterolaemia have been examined in a single-blind study. Simvastatin significantly reduced serum low density lipoprotein (LDL) cholesterol and triglycerides by 45% and 30%, respectivel

Short- and long-term effects of lovastat
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia
✍ B. G. Jacob; W. MΓΆhrle; W. O. Richter; P. Schwandt πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 612 KB

The effects of the HMG CoA reductase inhibitors lovastatin and pravastatin on serum lipids, lipoproteins and apolipoproteins have been studied in 35 patients with primary hypercholesterolaemia. LDL cholesterol was lowered to the same extent by both agents compared on a mg basis of each drug per day.